Annual Short Term Debt
$348.50 K
+$11.30 K+3.35%
December 31, 2023
Summary
- As of March 14, 2025, GANX annual short term debt is $348.50 thousand, with the most recent change of +$11.30 thousand (+3.35%) on December 31, 2023.
- During the last 3 years, GANX annual short term debt has risen by +$203.10 thousand (+139.68%).
- GANX annual short term debt is now at all-time high.
Performance
GANX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$297.10 K
-$800.00-0.27%
September 30, 2024
Summary
- As of March 14, 2025, GANX quarterly short term debt is $297.10 thousand, with the most recent change of -$800.00 (-0.27%) on September 30, 2024.
- Over the past year, GANX quarterly short term debt has dropped by -$51.40 thousand (-14.75%).
- GANX quarterly short term debt is now -14.75% below its all-time high of $348.50 thousand, reached on December 31, 2023.
Performance
GANX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
GANX Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.4% | -14.8% |
| 3 y3 years | +139.7% | -8.0% |
| 5 y5 years | - | -8.0% |
GANX Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +7.9% | -14.8% | at low |
| 5 y | 5-year | at high | +241.3% | -14.8% | +104.3% |
| alltime | all time | at high | +241.3% | -14.8% | +104.3% |
Gain Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $297.10 K(-0.3%) |
| Jun 2024 | - | $297.90 K(-5.5%) |
| Mar 2024 | - | $315.40 K(-9.5%) |
| Dec 2023 | $348.50 K(+3.4%) | $348.50 K(+2.4%) |
| Sep 2023 | - | $340.40 K(-2.0%) |
| Jun 2023 | - | $347.40 K(+1.7%) |
| Mar 2023 | - | $341.70 K(+1.3%) |
| Dec 2022 | $337.20 K | $337.20 K(+6.6%) |
| Sep 2022 | - | $316.20 K(+5.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $299.90 K(-3.0%) |
| Mar 2022 | - | $309.10 K(-4.3%) |
| Dec 2021 | $323.00 K(+122.1%) | - |
| Dec 2021 | - | $323.00 K(+25.7%) |
| Sep 2021 | - | $256.90 K(+4.1%) |
| Jun 2021 | - | $246.80 K(+48.9%) |
| Mar 2021 | - | $165.70 K(+14.0%) |
| Dec 2020 | $145.40 K(+42.4%) | - |
| Dec 2020 | - | $145.40 K |
| Dec 2019 | $102.10 K | - |
FAQ
- What is Gain Therapeutics annual short term debt?
- What is the all time high annual short term debt for Gain Therapeutics?
- What is Gain Therapeutics annual short term debt year-on-year change?
- What is Gain Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Gain Therapeutics?
- What is Gain Therapeutics quarterly short term debt year-on-year change?
What is Gain Therapeutics annual short term debt?
The current annual short term debt of GANX is $348.50 K
What is the all time high annual short term debt for Gain Therapeutics?
Gain Therapeutics all-time high annual short term debt is $348.50 K
What is Gain Therapeutics annual short term debt year-on-year change?
Over the past year, GANX annual short term debt has changed by +$11.30 K (+3.35%)
What is Gain Therapeutics quarterly short term debt?
The current quarterly short term debt of GANX is $297.10 K
What is the all time high quarterly short term debt for Gain Therapeutics?
Gain Therapeutics all-time high quarterly short term debt is $348.50 K
What is Gain Therapeutics quarterly short term debt year-on-year change?
Over the past year, GANX quarterly short term debt has changed by -$51.40 K (-14.75%)